Neon Therapeutics, Inc.
DelistedCIK 1694187fmd_055WJEQCT4SAZRPTFKWHN2R7X7Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2016 to Mar 31, 2020, 14 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|
| Research and development | 20 | 37 | 60 | 60 |
| Total operating expenses | 27 | 48 | 79 | 81 |
| Operating income | (27) | (48) | (79) | (81) |
| Interest and investment income | 0 | 1 | 2 | 1 |
| Other non-operating income (expense) | (0) | 1 | 2 | 1 |
| Net income | (27) | (48) | (77) | (80) |
| Net income to common shareholders | (30) | (58) | (83) | (80) |